Skip to content
value.today

Enzolytics Inc.

ENZC
$324 Mlast known market cap, Jan 2022 — no current value
Compare
World rank
—
no current market cap
Revenue
—
annual
Net income
—
Employees
—

Enzolytics Inc. in brief

Enzolytics Inc. is a listed company in the Biotechnology industry, based in the USA. Its last known market value was $324 M (January 2022); there is no current figure.

Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.

About Enzolytics Inc.

Enzolytics, Inc is a Drug Development company developing monoclonal antibody therapy and treating infectious diseases. The headquarters is in USA.

Market cap history

Not enough history yet.

Peer comparison · Biotechnology

CompanyMarket capP/ENet marginRev. growth
Enzolytics Inc.🇺🇸$324 M———
Novo Nordisk A/S🇩🇰$203.2 B13.1×33.1%+10.8%
Vertex Pharmaceuticals Incorporated🇺🇸$134.3 B33.8×30.7%+8.9%
Moderna, Inc.🇺🇸$90.1 B—-110.5%-39.9%
Regeneron Pharmaceuticals, Inc.🇺🇸$84.1 B17.5×28.5%+1.0%
Argenx SE🇳🇱$52.8 B40.9×31.1%+89.9%
CSL Limited🇦🇺$51.6 B—-16.4%—
Samsung Biologics Co., Ltd.🇰🇷$51.5 B40.5×39.2%—
UCB SA🇧🇪$48.6 B26.3×20.1%+31.1%

P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.

Questions, comparisons and similar companies#

Sources and freshness

Market cap:
Jan 7, 2022 (last known)
Profile updated:
Nov 4, 2026

Figures from value.today research.

How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.

Work at Enzolytics Inc.? Verify and update this profile — free

Use your work e-mail address (on the company's own domain if possible). Fill in only what is new or missing; a link to where the figures are published (annual report, press release) speeds up the review.

Show Enzolytics Inc.'s ranking on your website Get the badge
Badge preview

The badge updates itself as the ranking changes.

Something wrong or missing about Enzolytics Inc.? Suggest a correction